Clinical Trials Logo

Dialysis clinical trials

View clinical trials related to Dialysis.

Filter by:

NCT ID: NCT01685372 Completed - Dialysis Clinical Trials

Immunogenicity of Fluzone High Dose in Immunocompromised Children and Young Adults

Start date: September 2012
Phase: Phase 2
Study type: Interventional

The purpose of this study is to determine whether Fluzone High Dose increases the immune response to the influenza antigens contained in the vaccine compared to standard-dose Fluzone in immunocompromised children and young adults. Safety and efficacy data will also be collected.

NCT ID: NCT01421771 Completed - Hypertension Clinical Trials

Blood Pressure in Dialysis Patients

BID
Start date: October 2011
Phase: N/A
Study type: Interventional

Hypertension is a major cause of cardiovascular (CV) morbidity and mortality. Although studies in the general population have demonstrated a continuous reduction in CV risk with each mmHg drop in systolic blood pressure (SBP), multiple observational studies conducted in hemodialysis (HD) patients have demonstrated that patients with mild to moderate hypertension may have decreased mortality compared to those with normal blood pressure (BP). The investigators recently reported that among HD patients, those with routine pre-dialysis BP values that met the Kidney Disease Outcomes Quality Initiative (KDOQI) guidelines (<140/90 mm Hg) had increased mortality compared to patients with mild to moderate hypertension. However, these observational studies included untreated patients in whom low or normal BP may reflect significant cardiac disease or other comorbid conditions. In the setting of reduced vascular compliance and impaired autoregulation, aggressive BP lowering may decrease coronary or cerebral perfusion. Thus, it is unclear if aggressive BP lowering will be harmful or beneficial. A well-designed randomized control trial (RCT) is needed to answer this important question. Prior to conducting a full-scale RCT it is prudent to conduct a pilot study to assess feasibility and inform the design of the former. The investigators propose to conduct a pilot RCT in a prevalent cohort of HD patients to assess the safety and feasibility of treating patients to a low (110-140 mmHg)and standard (155-165) mm Hg pre-dialysis BP target.

NCT ID: NCT01414075 Completed - Anemia Clinical Trials

Study of Roxadustat (FG-4592) to Correct Anemia in Newly Initiated Dialysis Participants Not on Erythropoiesis-Stimulating Agent Treatment

Start date: July 21, 2011
Phase: Phase 2
Study type: Interventional

The purpose of this study is to evaluate efficacy and safety of roxadustat in the correction of anemia in participants with end-stage renal disease who recently started dialysis.

NCT ID: NCT01394770 Active, not recruiting - Hypertension Clinical Trials

Aliskiren or Amlodipine in Hypertensive Hemodialysed Patients

Start date: September 2009
Phase: Phase 4
Study type: Interventional

Hypertensive haemodialysis patients are at high risk for cardiovascular events. This study was undertaken to ascertain whether aliskiren, a direct renin inhibitor, compared with amlodipine, a calcium channel blocker, reduces mortality and cardiovascular events in these high-risk patients.

NCT ID: NCT01238588 Recruiting - Inflammation Clinical Trials

The Effect(s) of Sevelamer Carbonate (Renvela) on Atherosclerotic Plaque Inflammation Judged by FDG-PET Scan

Start date: November 2010
Phase: N/A
Study type: Interventional

The hypothesis is that switching calcium based phosphate binders to sevelamer carbonate will be associated with less inflammation including less atherosclerotic plaque inflammation (inflammation of the vessel walls).

NCT ID: NCT01174472 Completed - Dialysis Clinical Trials

Drug Eluting Balloon Angioplasty for Dialysis Access Treatment

Start date: March 2010
Phase: Phase 2/Phase 3
Study type: Interventional

The aim of the study is to compare the feasibility and the effectiveness, by means of immediate and long-term results, of drug eluting balloon (DEB) versus conventional balloon angioplasty for the treatment of failing dialysis access.

NCT ID: NCT01159054 Terminated - Inflammation Clinical Trials

Novel Pathways to Manage Inflammation and Atherosclerosis in Dialysis Patients: Role of Nicotinic Acid

Start date: July 2010
Phase: N/A
Study type: Interventional

Patients with kidney failure on hemodialysis have an extremely high rate of cardiovascular disease including atherosclerotic cardiovascular disease. This, at least in part, is due to the chronic inflammatory status usually seen in these patients. Here we try to see if treatment with extended release nicotinic acid (Niaspan) can reduce their overall inflammatory burden (in general) and the atherosclerotic plaque inflammation (in particular).

NCT ID: NCT01065389 Active, not recruiting - Clinical trials for End Stage Renal Disease

Resistance Training in Intradialysis Patients

DIAPRE
Start date: October 2010
Phase: Phase 2
Study type: Interventional

Dialysis patients usually have peripheral muscle weakness due to metabolic disturbances (increased protein catabolism) and fatigue. This muscle weakness may decrease functional capacity and quality of life. It also serves to increase cardiovascular risk factors in these end stage renal disease patients. Peripheral muscle strength training shall combat physical inactivity during dialysis. In the investigators trial, the investigators hypothesis that peripheral muscle training might regulate protein catabolic rate,renal functions, cardiovascular risk factors, improve functional capacity and quality of life in endstage renal disease patients undergoing dialysis.

NCT ID: NCT01059981 Completed - Dialysis Clinical Trials

Analysis of Emergency Department (ED) Volumes During Natural Disasters

Start date: August 2009
Phase: N/A
Study type: Observational

The 'Analysis of Emergency Department Volumes during Natural Disasters' retrospective study focuses on three specified populations including dialysis patients, trauma patients, and patients poisoned by carbon monoxide. These three populations have one commonality - hurricanes, ie. natural disasters, which is the exposure. Causal associations and significant correlations will be explored in all three subgroups.

NCT ID: NCT00858260 Completed - Dialysis Clinical Trials

Arnogene: A Phosphocalcic Study in Dialysis

ARNOGENE
Start date: November 2008
Phase: N/A
Study type: Observational

Searching for high morbi-mortality risk Klotho variants in dialysis patients